Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509

Clinical trial NCT00665145 · COMPLETED

Trial details

NCT number: NCT00665145
Sponsor: Sangamo Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 Diabetic Polyneuropathy

Start date: 2008-01-01
Primary completion: 2009-10-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.